美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

2倍做多NVO ETF-Defiance

11.48

-0.5700-4.73%

成交量：23.28萬

成交額：273.65萬

市值：3,005.58萬

市盈率：- -

高：12.15

開：12.14

低：11.48

收：12.05

52周最高：36.00

52周最低：9.23

股本：261.81萬

流通股本：261.81萬

量比：0.99

換手率：8.89%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

諾和諾德首席執行官：進行合併或收購的企業目前都陷入了某種困境，它們已經無法再開展創新了。

諾和諾德CEO力挺Wegovy口服片劑，售價下行拖累銷售，公司股價走低

环球市场播报

諾和諾德首席執行官：目前無意開展重大轉型式收購交易。

諾和諾德首席執行官：公司不會討論進一步降低藥品折扣。

諾和諾德Q2業績超預期、上調全年指引卻難掩隱憂

諾和諾德CEO業績展望上調，然研發管線隱憂未散，遭投資者質詢

諾和諾德首席財務官：我們目前沒有任何在未來推行成本削減的計劃。

諾和諾德首席執行官：減肥藥Wegovy口服劑型很快將在德國上市。

諾和諾德首席財務官：我們認為我們的定價定位合理。

諾和諾德首席財務官表示：目前Wegovy口服片劑主要由患者自費購買，受市場動態影響，未來價格大概率會出現調整。

諾和諾德首席執行官：CagriSema仍是一款藥效極強的藥物。

諾和諾德首席執行官表示：我們堅信，我們擁有極為充裕的研發管線，且研發能力十分出色。

諾和諾德首席執行官：Wegovy口服片已佔據口服肥胖症藥物市場約90%的份額.

諾和諾德首席執行官：全球有150萬人服用WEGOVY藥片。

諾和諾德在TRADEGATE平台上較哥本哈根收盤價下跌5.8%。

諾和諾德股價再度下挫，Wegovy口服藥銷售意外不及預期，美國注射劑表現同樣偏弱

老虎资讯综合

24小時環球政經要聞 | 8月5日

ETF日報 | 2倍做多Palantir ETF升逾58%；三倍做多半導體ETF漲近20%；科技與半導體槓桿領升

Wegovy生產商諾和諾德上調全年業績指引，減肥藥需求持續增長

环球市场播报

諾和諾德2026年業績前景改善，談及GLP-1銷售

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/NVOX/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"2倍做多NVO ETF-Defiance","latestPrice":11.48,"timestamp":1789586552982,"preClose":12.05,"halted":0,"volume":232821,"delay":0,"changeRate":-0.04730290456431537,"floatShares":2618100,"shares":2618100,"eps":0,"marketStatus":"交易中","change":-0.57,"latestTime":"09-16 15:23:04 EDT","open":12.14,"high":12.15,"low":11.48,"amount":2736497.4779339996,"amplitude":0.055602,"askPrice":11.49,"askSize":350,"bidPrice":11.48,"bidSize":1750,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":12.05,"sharesOutstanding":4098101,"nav":12.6,"aum":32988072.6,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":11.96,"preClose":12.05,"latestTime":"09:20 EDT","volume":13180,"amount":160697.55858,"timestamp":1789564823454,"change":-0.09,"changeRate":-0.007469,"amplitude":0.035685},"postHourTrading":{"tag":"盘后","latestPrice":12.08,"preClose":12.05,"latestTime":"19:30 EDT","volume":708,"amount":8545.8154,"timestamp":1789515006468,"change":0.03,"changeRate":0.00249,"amplitude":0.00249},"volumeRatio":0.994003,"impliedVol":0.6829,"impliedVolPercentile":0.228},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","floatShares":2618100,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.994003,"shares":2618100,"dividePrice":0,"high":12.15,"amplitude":0.055602,"preClose":12.05,"low":11.48,"week52Low":9.23,"pbRate":"--","week52High":36,"institutionHeld":0,"latestPrice":11.48,"committee":0.666667,"eps":0,"divideRate":0,"volume":232821,"delay":0,"ttmEps":0,"open":12.14,"prevYearClose":21.89,"prevWeekClose":12.39,"prevMonthClose":13.84,"prevQuarterClose":16.05,"fiveDayClose":13.3,"twentyDayClose":14.205,"sixtyDayClose":14.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-09","symbol":"NVOX","defaultRemindTime":1765290600000,"type":"split","dateTimestamp":1765256400000,"forFactor":8,"toFactor":1,"ratio":8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOX\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657510267","title":"諾和諾德首席執行官：進行合併或收購的企業目前都陷入了某種困境，它們已經無法再開展創新了。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510267","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510267?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 18:01","pubTimestamp":1785924082,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4599","LU1093756325.SGD","LU1093756168.USD","BK4007","NVOH","THNR","NVO","BK4532","NVOX","IE00BKVL7J92.USD","OZEM","LU0154236417.USD","IE00BZ1G4Q59.USD","PPH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657551275","title":"諾和諾德CEO力挺Wegovy口服片劑，售價下行拖累銷售，公司股價走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2657551275","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657551275?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 17:02","pubTimestamp":1785920520,"startTime":"0","endTime":"0","summary":"投资者持续聚焦价格压力、业绩超预期的可持续性，以及 Wegovy 口服片剂能否成为足够强劲的增长引擎，扭转公司增长颓势。诺和诺德坦言，产品降价持续拖累销售收入。不过 CEO 迈克杜斯塔达尔表示，销量持续攀升叠加 Wegovy 口服片剂初期销售表现，证明当前经营策略行之有效。周三交易开盘前，诺和诺德丹麦本土个股年内累计下跌约 5%；尽管 Wegovy 口服片剂上市后股价有所修复，但较 2024 年年中高点仍大跌近 70%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-05/doc-inimhawm4660383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVO","NVOX","OZEM","LU1093756168.USD","BK4585","PPH","BK4599","BK4532","BK4007","IE00BZ1G4Q59.USD","LU1093756325.SGD","IE00BKVL7J92.USD","NVOH","BK4588","THNR","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657511799","title":"諾和諾德首席執行官：目前無意開展重大轉型式收購交易。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657511799","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657511799?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 16:30","pubTimestamp":1785918656,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","NVO","BK4599","IE00BKVL7J92.USD","LU1093756168.USD","PPH","BK4007","LU1093756325.SGD","THNR","BK4532","NVOH","IE00BZ1G4Q59.USD","OZEM","LU0154236417.USD","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657511459","title":"諾和諾德首席執行官：公司不會討論進一步降低藥品折扣。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657511459","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657511459?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 16:26","pubTimestamp":1785918369,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","NVO","BK4599","IE00BKVL7J92.USD","LU1093756168.USD","PPH","BK4007","LU1093756325.SGD","THNR","BK4532","NVOH","IE00BZ1G4Q59.USD","OZEM","LU0154236417.USD","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657519148","title":"諾和諾德Q2業績超預期、上調全年指引卻難掩隱憂","url":"https://stock-news.laohu8.com/highlight/detail?id=2657519148","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657519148?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 15:49","pubTimestamp":1785916176,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德Q2业绩超预期、上调全年指引却难掩隐忧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","BK4007","NVO","NVOX","BK4588","LU1093756325.SGD","LU0154236417.USD","BK4599","THNR","IE00BKVL7J92.USD","PPH","OZEM","LU1093756168.USD","BK4585","IE00BZ1G4Q59.USD","NVOH"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2657403515","title":"諾和諾德CEO業績展望上調，然研發管線隱憂未散，遭投資者質詢","url":"https://stock-news.laohu8.com/highlight/detail?id=2657403515","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657403515?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 15:00","pubTimestamp":1785913213,"startTime":"0","endTime":"0","summary":"“Cagrisema再次令人失望，这可能凸显了诺和诺德面临的最大战略问题。”他表示，这些令人失望的结果将促使诺和诺德加快研发步伐并更加积极地寻求合作机会，而非变得更加谨慎。“这将诺和诺德的研发管线及其稳健性推到了聚光灯下，”AL Sydbank在致客户的报告中表示，并补充道，尽管诺和诺德的业绩本应让投资者松一口气，但这些数据和减值准备却打击了市场情绪。他表示，当务之急是扩大研发管线，同时保持生产效率的纪律性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL4S4420LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","OZEM","BK4599","BK4007","NVOX","THNR","LU1093756325.SGD","NVO","IE00BZ1G4Q59.USD","PPH","IE00BKVL7J92.USD","LU0154236417.USD","BK4532","BK4588","BK4585","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657251339","title":"諾和諾德首席財務官：我們目前沒有任何在未來推行成本削減的計劃。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657251339","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657251339?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 14:28","pubTimestamp":1785911326,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PPH","THNR","IE00BKVL7J92.USD","OZEM","BK4588","LU0154236417.USD","IE00BZ1G4Q59.USD","BK4007","BK4532","NVO","BK4585","LU1093756168.USD","NVOX","LU1093756325.SGD","NVOH","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657151338","title":"諾和諾德首席執行官：減肥藥Wegovy口服劑型很快將在德國上市。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657151338","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657151338?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 14:23","pubTimestamp":1785911038,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PPH","BK4599","IE00BZ1G4Q59.USD","NVO","IE00BKVL7J92.USD","BK4532","BK4585","LU1093756325.SGD","NVOH","LU1093756168.USD","LU0154236417.USD","BK4007","OZEM","NVOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657187875","title":"諾和諾德首席財務官：我們認為我們的定價定位合理。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657187875","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657187875?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 14:15","pubTimestamp":1785910546,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOH","OZEM","BK4599","BK4007","NVOX","THNR","LU1093756325.SGD","NVO","IE00BZ1G4Q59.USD","PPH","IE00BKVL7J92.USD","LU0154236417.USD","BK4532","BK4588","BK4585","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657518786","title":"諾和諾德首席財務官表示：目前Wegovy口服片劑主要由患者自費購買，受市場動態影響，未來價格大概率會出現調整。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657518786","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657518786?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 14:15","pubTimestamp":1785910533,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOX","IE00BKVL7J92.USD","PPH","BK4585","BK4599","BK4007","LU0154236417.USD","LU1093756325.SGD","THNR","OZEM","BK4588","BK4532","IE00BZ1G4Q59.USD","LU1093756168.USD","NVOH","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657518782","title":"諾和諾德首席執行官：CagriSema仍是一款藥效極強的藥物。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657518782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657518782?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 14:14","pubTimestamp":1785910446,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","NVO","BK4532","LU0154236417.USD","BK4588","LU1093756168.USD","NVOH","THNR","BK4007","OZEM","IE00BKVL7J92.USD","NVOX","LU1093756325.SGD","PPH","BK4585","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657518282","title":"諾和諾德首席執行官表示：我們堅信，我們擁有極為充裕的研發管線，且研發能力十分出色。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657518282","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657518282?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 14:12","pubTimestamp":1785910332,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOH","OZEM","BK4599","BK4007","NVOX","THNR","LU1093756325.SGD","NVO","IE00BZ1G4Q59.USD","PPH","IE00BKVL7J92.USD","LU0154236417.USD","BK4532","BK4588","BK4585","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657115518","title":"諾和諾德首席執行官：Wegovy口服片已佔據口服肥胖症藥物市場約90%的份額.","url":"https://stock-news.laohu8.com/highlight/detail?id=2657115518","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657115518?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 14:07","pubTimestamp":1785910062,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PPH","BK4007","BK4588","NVOH","NVO","LU1093756168.USD","BK4585","LU1093756325.SGD","IE00BZ1G4Q59.USD","NVOX","THNR","LU0154236417.USD","OZEM","BK4532","IE00BKVL7J92.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657751818","title":"諾和諾德首席執行官：全球有150萬人服用WEGOVY藥片。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657751818","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657751818?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 14:04","pubTimestamp":1785909894,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1093756325.SGD","BK4007","IE00BZ1G4Q59.USD","NVOH","NVOX","OZEM","PPH","BK4599","BK4585","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756168.USD","BK4532","NVO","THNR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657590904","title":"諾和諾德在TRADEGATE平台上較哥本哈根收盤價下跌5.8%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657590904","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657590904?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 13:34","pubTimestamp":1785908052,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PPH","BK4585","LU0154236417.USD","NVOX","NVO","THNR","IE00BKVL7J92.USD","BK4588","LU1093756168.USD","LU1093756325.SGD","OZEM","BK4532","IE00BZ1G4Q59.USD","BK4599","BK4007","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177186111","title":"諾和諾德股價再度下挫，Wegovy口服藥銷售意外不及預期，美國注射劑表現同樣偏弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1177186111","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177186111?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 10:42","pubTimestamp":1785897771,"startTime":"0","endTime":"0","summary":"诺和诺德提前公布第二季度业绩，Wegovy口服药销售额为322亿丹麦克朗，低于市场预期的332亿丹麦克朗，美国市场Wegovy注射剂销售也不及预期，拖累股价表现。虽然公司上调全年销售展望，二季度整体收入及肥胖药业务仍保持增长，但投资者对其GLP-1产品增长速度以及与礼来竞争的压力仍较为敏感。","market":"us","thumbnail":"https://community-static.tradeup.com/news/4c2ed3b4ebfd5dba1ba58ba649ecd2c2","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/4c2ed3b4ebfd5dba1ba58ba649ecd2c2"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","NVOH","NVOX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2657559520","title":"24小時環球政經要聞 | 8月5日","url":"https://stock-news.laohu8.com/highlight/detail?id=2657559520","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657559520?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 08:32","pubTimestamp":1785889933,"startTime":"0","endTime":"0","summary":"全球热点狙击","market":"sh","thumbnail":"https://img7.gelonghui.com/column/2/150.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/150.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5898774","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU1868836914.USD","LU0080751232.USD","LU1720051017.SGD","BK4599","SPCQ","LU1989764664.SGD","LU1400636657.SGD","LU2506952097.USD","IE000YTNTUN2.SGD","LU0323591593.USD","LU1989764748.USD","BK4512","LU0210528500.USD","LU2111349929.HKD","LU1301847155.USD","BK4588","LU0128525929.USD","LU1804176565.USD","LU1116320737.USD","LU1366192091.USD","BK4534","LU0345769631.USD","IE0034235303.USD","LU0314104364.USD","LU2430703178.SGD","LU0786609619.USD","LU0417517546.SGD","LU0472753341.HKD","IE00B19Z8X17.USD","IE00BMPRXR70.SGD","HK0000306685.HKD","TEK","HK0000819398.USD","LU0251132253.USD","LU1261432733.SGD","AMDU","LU0950375773.USD","LU2462591350.SGD","USXF","SG9999015945.SGD","IE0001KFT4U8.USD","LU0466842654.USD","LU0545039389.USD","GAMR","LU0345770993.USD","LU1066051225.USD","IE000W1ABFV2.USD","WARP","LU2092627202.USD","SMH","LU2237438978.USD","LU0511384066.AUD","LU0308772762.SGD","LU1244550577.SGD","LU1267930490.SGD","BK4576","LU0096362180.USD","LU0170899867.USD","LU0823417653.USD","XLK","BK4527","LU0289739343.SGD","LU0868494617.USD","LU0985320562.USD","LU1232071149.USD","LU2087625088.SGD","FAI","AAPB","LU2065171402.SGD","LU1815333072.USD","IE000MB6IJN5.SGD","LU2347655156.SGD","SG9999015341.SGD","SGXZ99366536.SGD","BK4554","LU1868837136.USD","IE00B1XK9C88.USD","LU1551013342.USD","LU1791710400.SGD","LU2458330243.SGD","IE0004445239.USD","LU0784383803.USD","IE0003U64NQ7.SGD","LU2417539215.USD","LU2360032135.SGD","BAI","LU2505996681.GBP","LU0390134368.USD","IE00BDRTCR15.USD","SPAX","SGXZ80539844.SGD","SG9999000418.SGD","LU2106854487.HKD","AAPL","LU1202635105.USD","LU2896262040.SGD","SG9999017495.SGD","BK4605","BK4581","CMAG","LU0965509010.AUD","BK4571","LU0719512351.SGD","LU2168564222.USD","LU1242518857.USD","HK0000320223.HKD","BK4553","LU0314106906.USD","AMDW","LU0274383776.USD","LU0820562030.AUD","LU0823434740.USD","SGXZ81514606.USD","LU1934455863.HKD","WUGI","SOXY","SG9999018865.SGD","NVO","AMDY","LU2860962120.EUR","BK4529","IE00BJLML261.HKD","ROM","LU2471134952.CNY","LU1803068979.SGD","AAPY","LU0289961442.SGD","LU2361044865.SGD","AMDS","LU2462591277.SGD","LU1074936037.SGD","LU2543165471.USD","LU2063271972.USD","LU0029864427.USD","LU0072461881.USD","LU1506573853.SGD","SG9999014567.USD","LU1868837300.USD","NVOH","IE00B19Z8W00.USD","LU1880398471.USD","LU1989772923.USD","LU1699723380.USD","LU0444973449.USD","LU0965508806.USD","LU2213496289.HKD","BK4559","LU1645745479.HKD","LU2023250843.SGD","LU2242650005.HKD","SG9999001424.SGD","SPCU","IE000WAW04H5.SGD","LU0077335932.USD","LU0133085943.USD","LU0162691827.USD","LU0057025933.USD","LU2097344357.USD","IE0009356076.USD","LU1035775433.USD","IE0004091025.USD","SG9999015978.USD","WISE","LU2077746001.SGD","SG9999015358.SGD","LU1629891620.HKD","LU1674673428.USD","BK4089","LU0868494708.USD","LU2746668461.USD","LU0097036916.USD","LU2361044949.HKD","BK4170","BK4598","LU0795875086.SGD","GB00BDT5M118.USD","LU2756315664.SGD","LU2756315318.SGD","AAPU","IE00BFSS8Q28.SGD","IE000F7OJYX1.SGD","IE0000B7K699.USD","LU2592432038.USD","LU2458330169.SGD","LU1496350502.SGD","LU1935042488.USD","LU2168564495.EUR","IE00BN29S564.USD","IE00BK4W5M84.HKD","LU0683600562.USD","LU1571399168.USD","AMDL","LU1145028129.USD","BK4612","LU2552382058.USD","LU1093756168.USD","ABFL","AMD","IE00B4YYXB79.USD","LU2552382215.SGD","LU0345768153.USD","LU2506951958.HKD","IXN","BK4575","IE00BKVL7J92.USD","OZEM","LU0345769128.USD","LU0444971666.USD","LU0949170772.SGD","IE00B7KXQ091.USD","LU0689626769.HKD","LU0354030438.USD","LU0072462426.USD","LU0784385170.HKD","BK4507","LU2357305700.SGD","IE00B775SV38.USD","LU1400636574.HKD","LU2452424414.USD","LU0109391861.USD","LU1280957306.USD","LU2108987350.USD","LU1974910355.USD","LU2247934214.USD","LU1066053197.SGD","AAPD","IE00B4JS1V06.HKD","LOFF","LU2237443465.HKD","LU2360107168.USD","METV","LU2381873111.SGD","LU0203201768.USD","LU0310800379.SGD","PSI","LU1206713676.USD","LU1642822529.SGD","LU0211327993.USD","LU1935042991.SGD","ARTY","LU0265550946.USD","LU2360106780.USD","AAPW","SG9999014898.SGD","LU1093756325.SGD","IE00BLSP4239.USD","IE00BWXC8680.SGD","LU2954938101.SGD","AMDG","LU1037948541.HKD","QQQA","LU0096364046.USD","LU1267930573.SGD","IE00B5949003.HKD","APLY","LU0942090050.USD","LU0456855351.SGD","IE00BK4W5L77.USD","LU0943347566.SGD","LU2168563687.JPY","IE000ITXATA3.USD","SG9999018857.SGD","CHPS","SG9999014575.USD","TTXU","SG9999014542.SGD","IE00BJTD4V19.USD","LU2361045086.USD","LU0353189680.USD","IE00BSNM7G36.USD","LU0053666078.USD","SPCH","BK4501","LU2100268510.USD","LU1366333091.USD","AIS","LU0256863902.USD","TTEQ","LU2750360997.AUD","LU1003077747.HKD","LU0912757837.SGD","LU2047632596.USD","SG9999014880.SGD","LU0124676726.USD","XNTK","LU0957791311.USD","LU2471134879.HKD","LU0203202063.USD","AIQ","FTEC","LU1267930813.SGD","LU1548497426.USD","LU2931357623.SGD","LU0354030511.USD","LU1066051498.USD","LU1720051108.HKD","AAPX","LU2237443895.HKD","BK4007","BK4141","LU0979878070.USD","LU1814569148.SGD","HK0000306701.USD","LU0158827781.USD","BK4505","LU1868836591.USD","LU1582987597.SGD","LU2237443622.USD","HK0000914686.HKD","IE00BJJMRX11.SGD","LU0345770308.USD","SNK","LU2097344431.USD","SG9999014914.USD","LU2168564065.EUR","IE00B775H168.HKD","LU0061475181.USD","IE00BMPRXQ63.HKD","LU2065171311.SGD","LU0965509283.SGD","LU0157215616.USD","LU0215105999.USD","LU2125154778.USD","DAMD","LU0494093205.USD","WSPC","IE00BZ1G4Q59.USD","LU0316494557.USD","SOXX","IE00BLSP4452.SGD","LU0081259029.USD","IE000KEQY171.SGD","LU1852331112.SGD","IE00B1BXHZ80.USD","LU0726765562.USD","LU0265550359.USD","AMUU","LU2089283258.USD","LU0889566641.SGD","LU1066051811.HKD","LU1935043023.USD","IE00B3S45H60.SGD","LU0348723411.USD","LU0823417737.USD","LU2133065610.SGD","LU2487616109.SGD","LU0820561818.USD","LU2347655073.USD","LU1400636491.USD","LU0082616367.USD","LU2168564149.EUR","LU2191332357.HKD","BK4579","LU0738911758.USD","LU1988902786.USD","LU1244550221.USD","IE00BQXX3F31.USD","LU2023250330.USD","LU1868836757.USD","LU2271345857.HKD","LU0149725797.USD","BK4614","LU2506951875.HKD","MARS","LU2456880835.USD","LU2065169927.USD","SGXZ51526630.SGD","IE00BFSS7M15.SGD","LU0154236417.USD","LU2462157665.USD","BK4566","LU2083900584.USD","LU0792757196.USD","LU0070302665.USD","LU0079474960.USD","IE00BKDWB100.SGD","LU2506952170.USD","LU1791710582.SGD","LU1582986433.USD","LU1496350171.SGD","LU2237443549.SGD","LU1244550494.USD","LU0174119429.USD","LU1917777945.USD","LU0784385840.USD","IE000BZT7R73.USD","THNR","LU2355687059.USD","BK4592","PPH","LU1046421795.USD","LU1778281490.HKD","LU1674673691.USD","IE00BQXX3C00.GBP","LU0795875169.SGD","LU1861559042.SGD","LU1923623000.USD","LU1989772840.SGD","LU0949170426.SGD","MACW.SI","SG9999014906.USD","IE00BN8TJ469.HKD","TYLG","SG9999015986.USD","SPTE","LU1119994496.HKD","LU2505996509.AUD","LU1861220033.SGD","LU1951198990.SGD","LU1127390331.HKD","LU0708995401.HKD","SGXZ31699556.SGD","SPAL","LU0724617625.USD","LU1914381329.SGD","IE00B19Z9505.USD","LU2420271590.USD","LU0011850046.USD","ILDR","BK4543","LU0784384876.USD","LU2065170008.USD","LU2746668974.SGD","HK0000914660.USD","LU0882574139.USD","LU0889565833.HKD","LU1037948897.HKD","LU1732800096.USD","LU0127658192.USD","LU2471134523.USD","LU2236285917.USD","LU0823421333.USD","LU0210533765.USD","LU0234572021.USD","LU2264538146.SGD","LU1951200564.SGD","LU2098885051.SGD","SPCX","LU1989771016.USD","SPCG","LU0310799852.SGD","LU1303367103.USD","BK4515","LU2028103732.USD","LU0061474960.USD","LU0320765489.SGD","LU0861579265.USD","LU0672654240.SGD","LU0210536198.USD","LU0070217475.USD","IE0034235295.USD","BK4585","LU1206712785.SGD","LU0788109477.HKD","LU0211328371.USD","LU1979441026.SGD","IE00BJTD4N35.SGD","LU2023250504.SGD","LU2237443382.USD","LU2430703095.HKD","LU1718418525.SGD","AMYY","LU1823568750.SGD","LU1316542783.SGD","LU3102509885.SGD","BK4532","LU1861215975.USD","LU2089985449.USD","IE0004445015.USD","LU1839511570.USD","IE00BYXW3230.USD","IE00BBT3K403.USD","IETC","LU0661504455.SGD","LU2290526834.HKD","TRFK","LU1084165304.USD","LU1934455277.USD","LU2403377893.USD","SSPC","LU2552382132.HKD","LU0143551892.USD","LU1880398554.USD","LU2286300806.USD","LU0823421416.USD","LU0158827948.USD","LU0642271901.SGD","IE0009G5SDU7.USD","LU0048584097.USD","LU2125154935.USD","IE00BMPRXN33.USD","LU0787776722.HKD","LU0820561909.HKD","LU0353189763.USD","LU0056508442.USD","LU0345768740.USD","LU1582986359.USD","SG9999015952.SGD","LU2602419157.SGD","LU1242518931.SGD","LU0208291251.USD","LU2430703251.USD","LU2637965513.SGD","JGRO","LU1934455194.USD","LU0957808578.USD","LEGR","LU2237443978.SGD","LU2242649171.HKD","IE0004086264.USD","LU2265009873.SGD","LU2054465674.USD","LU0528227936.USD","LU1582987324.SGD","LU0069063385.USD","BK4574","VGT","IE000Q6AESB8.SGD","BK4550","IE00BJJMRY28.SGD","LU1861558580.USD","LU0553294199.USD","AMDD","HK0000532082.HKD","NVOX","LU2092937148.SGD","LU1935043536.SGD","BK4573","IE00BDCRKT87.USD","LU2087621335.USD","SG9999014559.SGD","LU0238689110.USD","LU1116320901.HKD","SPCF","LU1235294995.USD","LU0640476718.USD","LU2461242641.AUD","LU1069344957.HKD","LU0234570918.USD","IE000SO60NU8.SGD","CNAV","LU0256863811.USD","LU2750360641.GBP","VT","BK4533","CHAT","LU2999663052.SGD","LU2089284900.SGD","SG9999002232.USD","LU0476273544.USD","SMHX","IE00BQXX3D17.EUR","LU1815336760.USD","ORBX","HK0000320264.USD","LU0198837287.USD","LU1670756490.USD","LU1267930730.SGD","LU0689472784.USD","LU0823434583.USD","LU1732799900.SGD","LU1551013425.SGD","IE0005OL40V9.USD","LU0109392836.USD","LU0964807845.USD","LU0965509101.SGD","LU0320765059.SGD","LU1291159041.SGD","LU0267386448.USD","SPCM","FTXL","LU1064131342.USD","IE00B3SWFQ91.USD","LU2471134796.USD","LU2023251221.USD","LU1935042215.USD","LU2250418816.HKD","LU0708994859.HKD","LU0557290698.USD","SG9999002224.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107495864","title":"ETF日報 | 2倍做多Palantir ETF升逾58%；三倍做多半導體ETF漲近20%；科技與半導體槓桿領升","url":"https://stock-news.laohu8.com/highlight/detail?id=1107495864","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107495864?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:07","pubTimestamp":1785874020,"startTime":"0","endTime":"0","summary":"ETF层面，单一科技股相关杠杆产品涨幅居前，做空与反向产品普遍承压。美股ETF涨幅Top52倍做多PLTR ETF-Corgi上涨58.48%。多家媒体称Palantir上调全年及中期收入预期，并表示商业需求强劲，相关消息带动公司股价走强。2倍做多PLTR ETF-GraniteShares上涨58.03%。该产品两倍做空Palantir，底层公司股价走强，杠杆机制放大当日跌幅。1倍做空PLTR ETF-Direxion下跌29.21%。三倍做多MSCI新兴市场ETF-Direxion上涨7.65%。行业指数ETF涨幅Top 5三倍做多半导体ETF-Direxion Daily上涨19.87%。债券ETF涨幅Top 5First Trust SSI Strategic Convertible Securities ETF上涨2.21%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEKX","USO","SMAX","SPUU","VGT","NVTC","HIBL","03086","ALA","IWM","PLTL","AUAU","SGDJ","GLDM","QDEC","UGA","GUNR","DBE","BNO","GBUG","LU1861559042.SGD","PLT","SCHK","DIG","SSG","UPRO","SPYQ","FTXL","PSQ","YSPY","BK4023","GUSH","NJAN","PFXF","BK4007","DBC","DRIP","WTIU","BK4593","XITK","VDE","USG","IE00B66KJ199.SGD","RING","AAAU","IXC","UWM","NBDS","DGP","NUGY","QQQX","SOXL","PICK","XSD","MVV","BK4547","DRLL","LU1861558580.USD","512480","ETNG","ICVT","EDC","AAOX","SPXS","USL","TECY","XLK","UYM","AIPI","ONTX","CHPS","EDZ","PXJ","DUG","OILT","NVOX","QSWN","IE00B19Z9P08.USD","SOXS","SPYH","SHNY","VOO","IGLD","SGOL","SH","XW","BK4550","SPYU","UCO","ZSL","MIDU","OILK","SOXX","VRC","FWD","CIFU","GDXY","IE00B894F039.SGD","USOI","AGQ","09834","AAOZ","NVOH","SLV","JDST","LAZR","GLD","EIS","GDXU","OUNZ","SPDN","IAUI","IE0031619046.USD","CEF","159582","IE00B19Z9Z06.USD","JNUG","GLDW","KGLD","OIH","DBO","GLTR","GOLY","SMH","DUST","BGLD","TNA","PBUG","NANR","TWM","NOCT","BK4588","VTWO","BK4020","JGLD","GOAU","IE00B7SZL793.SGD","GDXJ","QQQW","UMDD","LITC","07522","DGZ","BEGS","UXAP","EYES","GDXW","SOXQ","QMAR","GDX","SAA","EEMO","ERX","USD","GLL","GUNZ","SOXY","QQQM","BK4585","BTGD","NAPR","FAAR","SQQQ","03034","07568","EWY","IE00BZ9MQY76.HKD","IVV","BK7062","QID","RWM","IGV","OSSL","02834","SHLD","BK4535","SPXU","QLD","CWC","CHPY","TEUP","CIFG","TZA","TQQY","IAUM","GLDY","XME","BK4543","SMHX","QQQ","FCVT","09086","SIMX","YGLD","PLTG","PSI","SPXL","SGDM","IAU","PALL","IEO","07261","FDN","RGTC","SCO","TAN","CWB","DULL","DZZ","HAP","IE00B19Z4B17.USD","07266","GPIQ","PSCM","DMAX","SPY","SPYM","UGL","BK4613","FGDL","MMAX","COZX","SPTL","03455","FTXN","URTY","BAR","NUGT","SSO","SDS","TQQQ","USE","MQQQ","NBIC","CCNR","XES","OILU","PHYS","SIVR","PXE","GDXD","NJUL"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2657659065","title":"Wegovy生產商諾和諾德上調全年業績指引，減肥藥需求持續增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2657659065","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657659065?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 02:52","pubTimestamp":1785869520,"startTime":"0","endTime":"0","summary":"　　$诺和诺德$表示，由于减肥药需求未见减弱迹象，其全年销售额和营业利润的降幅将低于此前预期。　　分析师此前已预期诺和诺德会上调全年指引，因为自$美国食品$药品监督管理局于2021年首次批准Wegovy作为减肥药物以来，该药已大幅推动公司销售额增长。欧盟同时还批准了Wegovy单剂量注射笔剂型。但投资者更为关注的经调整营业利润增长11%，至333.9亿丹麦克朗。","market":"us","thumbnail":"https://static.tigerbbs.com/cf00d3e001bd81b11eb9b57bd44b96ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/cf00d3e001bd81b11eb9b57bd44b96ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-05/doc-inimevcc1764804.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4007","LU1093756325.SGD","BK4585","LU0154236417.USD","BK4599","NVOH","OZEM","LU1093756168.USD","NVO","BK4532","BK4588","NVOX","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657563316","title":"諾和諾德2026年業績前景改善，談及GLP-1銷售","url":"https://stock-news.laohu8.com/highlight/detail?id=2657563316","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657563316?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 01:23","pubTimestamp":1785864197,"startTime":"0","endTime":"0","summary":"诺和诺德预计本财年固定汇率口径调整后销售额同比-6%至0%，分析师预期为-5.9%。第二季度固定汇率下调整后销售额增长7%；固定汇率下调整后营业利润增长11%。第二季度调整后销售额784.9亿丹麦克朗，调整后营业利润333.9亿丹麦克朗。二季度调整后Ozempic销售313.8亿丹麦克朗，Wegovy针剂销售194.8亿克朗、药丸销售32.2亿克朗（分析师预期32.2亿克朗）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608053831561145.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608053831561145.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4599","BK4532","BK4588","LU0154236417.USD","BK4007","NVOX","LU1093756325.SGD","IE00BKVL7J92.USD","NVOH","IE00BZ1G4Q59.USD","PPH","BK4585","THNR","OZEM","LU1093756168.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}